Drawing for VIVRA AT SILVERADO

USPTO serial 87459217

VIVRA AT SILVERADO

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
—
Law office
NEW APPLICATION PROCESSING

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIVRA AT SILVERADO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rachel Saldana

RACHEL SALDANA SALDANA IP2601 N. QUINLAN PARK ROADSUITE 508Austin, TX 78732

Goods and services

ClassDescriptionStatusFirst use
044Medical services, namely, services provided by registered nurses, nurse practitioners, and related medical professions; Clinical oversight services, namely, monitoring the status of senior citizens suffering from chronic illness or disease, undergoing cancer treatment therapies, suffering from diabetes, or awaiting an organ transplant; Medication management services, namely, preparation of and dispensing of medicationsACTIVEApr 1, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 6, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 6, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 28, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 15, 2017MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT—
Aug 15, 2017ABN1ABANDONMENT - EXPRESS MAILED—
Aug 14, 2017EXARTEAS EXPRESS ABANDONMENT RECEIVED—
May 26, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 25, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance